Just a bit more of what Edwards are doing. Not relevant to AVR but perhaps a future opportunity -
"Edwards Lifesciences has secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive a regulatory green light."
Link to full article below -
Edwards Lifesciences claims European approval for transcatheter tricuspid valve implant (fiercebiotech.com)
Just a bit more of what Edwards are doing. Not relevant to AVR...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.51 |
Change
-0.490(3.50%) |
Mkt cap ! $285.5M | |||
| Open | High | Low | Value | Volume |
| $14.05 | $14.05 | $13.40 | $234.3K | 17.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.70 | 614 | 1 |
View Market Depth
| Last trade - 15.59pm 08/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |